{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,24]],"date-time":"2026-08-24T07:20:46Z","timestamp":1787556046655,"version":"build-2736575974"},"reference-count":24,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,7,23]],"date-time":"2026-07-23T00:00:00Z","timestamp":1784764800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,8,24]],"date-time":"2026-08-24T00:00:00Z","timestamp":1787529600000},"content-version":"vor","delay-in-days":32,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"the National Natural Science Foundation for Young Scientists of China"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Discov Onc"],"DOI":"10.1007\/s12672-026-05623-8","type":"journal-article","created":{"date-parts":[[2026,7,23]],"date-time":"2026-07-23T12:48:18Z","timestamp":1784810898000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Immune-related gene signature for predicting biochemical recurrence after RP in prostate cancer subtypes"],"prefix":"10.1007","volume":"17","author":[{"given":"Yiwei","family":"Lin#","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiatong","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,23]]},"reference":[{"issue":"12","key":"5623_CR1","doi-asserted-by":"publisher","first-page":"1749","DOI":"10.1001\/jamaoncol.2019.2996","volume":"5","author":"F Abd-Allah","year":"2019","unstructured":"Abd-Allah F, et al. Global, Regional, and National Cancer Incidence, Mortality, Years of Life Lost, Years Lived With Disability, and Disability-Adjusted Life-Years for 29 Cancer Groups, 1990 to 2017: A Systematic Analysis for the Global Burden of Disease Study. JAMA Oncol. 2019;5(12):1749.","journal-title":"JAMA Oncol"},{"key":"5623_CR2","doi-asserted-by":"crossref","unstructured":"Mottet N et al. EAU-ESTRO-SIOG guidelines on prostate cancer. Part 1: screening, diagnosis, and local treatment with curative intent. Eur Urol. 2016: p. 618.","DOI":"10.1016\/j.eururo.2016.08.003"},{"issue":"4","key":"5623_CR3","doi-asserted-by":"publisher","first-page":"1548","DOI":"10.1016\/S0022-5347(05)68359-0","volume":"162","author":"CR Pound","year":"1999","unstructured":"Pound CR, et al. Natural History of Progression After PSA Elevation Following Radical Prostatectomy. J Urol. 1999;162(4):1548.","journal-title":"J Urol"},{"key":"5623_CR4","unstructured":"Hitoshi I et al. The effects of PSA kinetics on the outcome of hypofractionated salvage radiotherapy for biochemical recurrence of prostate cancer after prostatectomy. J Radiat Res (2020)."},{"issue":"6","key":"5623_CR5","first-page":"692","volume":"27","author":"AS Kibel","year":"2009","unstructured":"Kibel AS. Phase III postoperative adjuvant radiotherapy after radical prostatectomy compared with radical prostatectomy alone in pT3 prostate cancer with postoperative undetectable prostate-specific antigen: ARO 96\u2009\u2013\u200902\/AUO AP 09\/95. J Clin Oncol. 2009;27(6):692\u20133.","journal-title":"J Clin Oncol"},{"key":"5623_CR6","doi-asserted-by":"crossref","unstructured":"Shi R et al. A novel gene signature-based model predicts biochemical recurrence-free survival in prostate cancer patients after radical prostatectomy. Cancers (Basel). 2019;12(1):1.","DOI":"10.3390\/cancers12010001"},{"issue":"18","key":"5623_CR7","doi-asserted-by":"publisher","first-page":"6492","DOI":"10.1002\/cam4.4092","volume":"10","author":"Q Su","year":"2021","unstructured":"Su Q, et al. Gene signatures predict biochemical recurrence-free survival in primary prostate cancer patients after radical therapy. Cancer Med. 2021;10(18):6492\u2013502.","journal-title":"Cancer Med"},{"key":"5623_CR8","doi-asserted-by":"crossref","unstructured":"Long G et al. Identification of a DNA repair gene signature and establishment of a prognostic nomogram predicting biochemical-recurrence-free survival of prostate cancer. Front Mol Biosci. 2021;8:608369.","DOI":"10.3389\/fmolb.2021.608369"},{"issue":"12","key":"5623_CR9","doi-asserted-by":"publisher","first-page":"1402","DOI":"10.1200\/JCO.2015.64.2702","volume":"34","author":"HI Scher","year":"2016","unstructured":"Scher HI, et al. Trial Design and Objectives for Castration-Resistant Prostate Cancer: Updated Recommendations From the Prostate Cancer Clinical Trials Working Group 3. J Clin oncology: official J Am Soc Clin Oncol. 2016;34(12):1402\u201318.","journal-title":"J Clin oncology: official J Am Soc Clin Oncol"},{"issue":"6","key":"5623_CR10","doi-asserted-by":"publisher","first-page":"643","DOI":"10.1097\/MOU.0000000000001038","volume":"32","author":"G Wasinger","year":"2022","unstructured":"Wasinger G, et al. Histological patterns, subtypes and aspects of prostate cancer: different aspects, different outcomes. Curr Opin Urol. 2022;32(6):643\u20138.","journal-title":"Curr Opin Urol"},{"issue":"1","key":"5623_CR11","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1038\/s41467-023-36325-2","volume":"14","author":"T Hirz","year":"2023","unstructured":"Hirz T, et al. Dissecting the immune suppressive human prostate tumor microenvironment via integrated single-cell and spatial transcriptomic analyses. Nat Commun. 2023;14(1):663.","journal-title":"Nat Commun"},{"issue":"1","key":"5623_CR12","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1038\/s41698-024-00667-x","volume":"8","author":"S Cheng","year":"2024","unstructured":"Cheng S, et al. Unveiling novel double-negative prostate cancer subtypes through single-cell RNA sequencing analysis. NPJ precision Oncol. 2024;8(1):171.","journal-title":"NPJ precision Oncol"},{"key":"5623_CR13","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1186\/1471-2105-14-7","volume":"14","author":"S Hanzelmann","year":"2013","unstructured":"Hanzelmann S, Castelo R, Guinney J. GSVA: gene set variation analysis for microarray and RNA-seq data. BMC Bioinformatics. 2013;14:7.","journal-title":"BMC Bioinformatics"},{"key":"5623_CR14","doi-asserted-by":"crossref","unstructured":"Taosheng et al. Cancersubtypes: an R\/bioconductor package for molecular cancer subtype identification, validation and visualization. Bioinformatics. 2017;33(19):3131\u20133133.","DOI":"10.1093\/bioinformatics\/btx378"},{"key":"5623_CR15","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1016\/j.nicl.2014.08.023","volume":"6","author":"AV Lebedev","year":"2014","unstructured":"Lebedev AV, et al. Random Forest ensembles for detection and prediction of Alzheimer\u2019s disease with a good between-cohort robustness. NeuroImage: Clin. 2014;6:115\u201325.","journal-title":"NeuroImage: Clin"},{"issue":"3","key":"5623_CR16","doi-asserted-by":"publisher","first-page":"888","DOI":"10.1016\/j.ajog.2005.09.002","volume":"194","author":"WA Grobman","year":"2006","unstructured":"Grobman WA, Stamilio DM. Methods of clinical prediction. Am J Obstet Gynecol. 2006;194(3):888\u201394.","journal-title":"Am J Obstet Gynecol"},{"issue":"2","key":"5623_CR17","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1002\/pros.24448","volume":"83","author":"S Cheng","year":"2023","unstructured":"Cheng S, Yu X. CTPC, a combined transcriptome data set of human prostate cancer cell lines. Prostate. 2023;83(2):158\u201361.","journal-title":"Prostate"},{"issue":"13","key":"5623_CR18","doi-asserted-by":"publisher","first-page":"1521","DOI":"10.1016\/S1470-2045(14)71021-6","volume":"15","author":"ELA C","year":"2014","unstructured":"C ELA, et al. Tumour genomic and microenvironmental heterogeneity for integrated prediction of 5-year biochemical recurrence of prostate cancer: a retrospective cohort study. Lancet Oncol. 2014;15(13):1521\u201332.","journal-title":"Lancet Oncol"},{"issue":"1","key":"5623_CR19","doi-asserted-by":"publisher","first-page":"1851950","DOI":"10.1080\/2162402X.2020.1851950","volume":"9","author":"B Vittrant","year":"2020","unstructured":"Vittrant B, et al. Immune-focused multi-omics analysis of prostate cancer: leukocyte Ig-Like receptors are associated with disease progression. Oncoimmunology. 2020;9(1):1851950.","journal-title":"Oncoimmunology"},{"issue":"11","key":"5623_CR20","doi-asserted-by":"publisher","first-page":"1849","DOI":"10.1007\/s00432-014-1738-8","volume":"140","author":"K Litovkin","year":"2014","unstructured":"Litovkin K, et al. Methylation of PITX2, HOXD3, RASSF1 and TDRD1 predicts biochemical recurrence in high-risk prostate cancer. J Cancer Res Clin Oncol. 2014;140(11):1849\u201361.","journal-title":"J Cancer Res Clin Oncol"},{"issue":"3","key":"5623_CR21","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1007\/s11255-019-02096-3","volume":"51","author":"F Li","year":"2019","unstructured":"Li F, Xu Y, Liu R. SAMD5 mRNA was overexpressed in prostate cancer and can predict biochemical recurrence after radical prostatectomy. Int Urol Nephrol. 2019;51(3):443\u201351.","journal-title":"Int Urol Nephrol"},{"issue":"8","key":"5623_CR22","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1007\/s11912-018-0707-9","volume":"20","author":"A Kaveri","year":"2018","unstructured":"Kaveri A, Barbieri CE. Molecular Subtypes of Prostate Cancer. Curr Oncol Rep. 2018;20(8):58.","journal-title":"Curr Oncol Rep"},{"issue":"11","key":"5623_CR23","doi-asserted-by":"publisher","first-page":"1900038","DOI":"10.1002\/pmic.201900038","volume":"19","author":"M Shahid","year":"2019","unstructured":"Shahid M, et al. Downregulation of CENPF Remodels Prostate Cancer Cells and Alters Cellular Metabolism. Proteomics. 2019;19(11):1900038.","journal-title":"Proteomics"},{"issue":"5","key":"5623_CR24","doi-asserted-by":"publisher","first-page":"638","DOI":"10.1016\/j.ccr.2014.03.017","volume":"25","author":"A Aytes","year":"2014","unstructured":"Aytes A, et al. Cross-species regulatory network analysis identifies a synergistic interaction between FOXM1 and CENPF that drives prostate cancer malignancy. Cancer Cell. 2014;25(5):638\u201351.","journal-title":"Cancer Cell"}],"container-title":["Discover Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12672-026-05623-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12672-026-05623-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12672-026-05623-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,24]],"date-time":"2026-08-24T06:38:11Z","timestamp":1787553491000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12672-026-05623-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,23]]},"references-count":24,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["5623"],"URL":"https:\/\/doi.org\/10.1007\/s12672-026-05623-8","relation":{},"ISSN":["2730-6011"],"issn-type":[{"value":"2730-6011","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,23]]},"assertion":[{"value":"26 March 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 July 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 July 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"No ethics approval was required for the study. No consent was required for the study.","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"No application.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"1231"}}